<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231120060114N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-25</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Investigating the effect of acceptance and commitment and matrix therapy in addiction prevention</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effectiveness of Acceptance and Commitment Therapy (ACT) and Matrix in preventing relapse in patients with substance abuse</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74082</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Substance use disorders.</hc_freetext>
      <i_freetext>Intervention 1: Control group: In this group, treatment intervention is not performed. Intervention 2: The first intervention group: therapeutic intervention based on acceptance and commitment (ACT): these therapeutic sessions are organized based on the intervention of Hayes and Wilson (2014). In the present study, the patients of the first intervention group participate in eight group sessions during two months. There are two sessions every week and each session lasts 90 minutes. The content of the sessions is as follows: First session: getting to know the members, stating the topic and goals of the treatment and the number of sessions, conducting the pre-test. The second session: general familiarity with acceptance and commitment therapy and its role in regulating emotions and how it affects reducing drug use. The third session: explaining the treatment components and using the necessary metaphors in Inford, giving homework. Session 4: Reviewing homework, examining ineffective strategies and abandoning them, practicing techniques. The fifth session: Reviewing homework, explaining the effect of exercises and reviewing members' assignments and practicing the sequence of techniques. Session 6: Homework review, self-acceptance and self-belief, creating a sense of superiority in oneself (along with parables). Session 7: Making a commitment to valuable actions and practicing relapse prevention (with examples). The eighth session: review of all sessions and presentation of final strategies and post-test implementation. Intervention 3: The second intervention group: Matrix therapy: Matrix therapy was invented in 1980 by an American institution with the aim of helping people quit drugs and stimulants such as cocaine and glass. In this research, the fourth edition of Matrix Incas treatment protocol (Makri, 2013) was used. Matrix therapy sessions in this research are held in 8 sessions, 2 sessions a week in groups and each session lasts 90 minutes for the participants of the experimental group. The content of these sessions is as follows: First session: scale of change (why do we leave materials?). Second session: initiators (triggers, triggers, ...), internal initiators, external initiators. The third session: the course of recovery, major problems in recovery (distrust of family and surrounding people, loss of energy). The fourth session: Temptation and the right and wrong ways to deal with it. The fifth session: Thoughts and feelings underlying consumption, activities that prevent and predispose to relapse. Session 6: work, guilt, recovery motivation. The seventh session: truthfulness, complete purity. Session 8: Addictive sexual relationships, behaviors and thoughts related to relapse and its prediction.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The main outcome data of the research and the results of the data analysis are shared.

When:
The access period starts 6 months after the results are published

To whom:
Researchers working in universities, psychotherapy and psychology centers

Conditions:
Data and documents can be sent without mentioning the name of the participants. Necessary conditions for performing statistical analyzes are obtaining permission from the authors of the research and the ethics committee of the university.

Where to obtain:
Refer to the authors of the research (student and supervisor), Islamic Azad University, Maroodasht branch and the journal in which the article related to this research will be published.

How to obtain:
Submitting an application to the Islamic Azad University of Maroodasht branch and progressing the administrative steps of the issue process in the university's research vice-chancellor

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farzaneh zare</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University of Marvdasht,Kilometer three of Takht Jamshid Blvd,Marvdasht</address>
        <city>Marvdasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7371113119</zip>
        <telephone>+98 71 4331 1172</telephone>
        <email>admin@miau.ac.ir</email>
        <affiliation>The Islamic Azad University of Marvdasht</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farzaneh zare</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University of Marvdasht , Killometer three of Takht Jamshid Blvd , Marvdasht</address>
        <city>Marvdasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7371113119</zip>
        <telephone>+98 71 4331 1172</telephone>
        <email>admin@miau.ac.ir</email>
        <affiliation>Islamic Azad University of Marvdasht</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having informed consent for the study
Lack of regular use of neuropsychiatric drugs</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having incurable physical diseases
Suffering from chronic psychological diseases under the approval of a psychologist or psychiatrist</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F11.18</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Opioid abuse with other opioid-induced disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: In this group, treatment intervention is not performed</i_keyword>
      <i_keyword>The first intervention group: therapeutic intervention based on acceptance and commitment (ACT): these therapeutic sessions are organized based on the intervention of Hayes and Wilson (2014). In the present study, the patients of the first intervention group participate in eight group sessions during two months. There are two sessions every week and each session lasts 90 minutes. The content of the sessions is as follows: First session: getting to know the members, stating the topic and goals of the treatment and the number of sessions, conducting the pre-test. The second session: general familiarity with acceptance and commitment therapy and its role in regulating emotions and how it affects reducing drug use. The third session: explaining the treatment components and using the necessary metaphors in Inford, giving homework. Session 4: Reviewing homework, examining ineffective strategies and abandoning them, practicing techniques. The fifth session: Reviewing homework, explaining the effect of exercises and reviewing members' assignments and practicing the sequence of techniques. Session 6: Homework review, self-acceptance and self-belief, creating a sense of superiority in oneself (along with parables). Session 7: Making a commitment to valuable actions and practicing relapse prevention (with examples). The eighth session: review of all sessions and presentation of final strategies and post-test implementation.</i_keyword>
      <i_keyword>The second intervention group: Matrix therapy: Matrix therapy was invented in 1980 by an American institution with the aim of helping people quit drugs and stimulants such as cocaine and glass. In this research, the fourth edition of Matrix Incas treatment protocol (Makri, 2013) was used. Matrix therapy sessions in this research are held in 8 sessions, 2 sessions a week in groups and each session lasts 90 minutes for the participants of the experimental group. The content of these sessions is as follows: First session: scale of change (why do we leave materials?). Second session: initiators (triggers, triggers, ...), internal initiators, external initiators. The third session: the course of recovery, major problems in recovery (distrust of family and surrounding people, loss of energy). The fourth session: Temptation and the right and wrong ways to deal with it. The fifth session: Thoughts and feelings underlying consumption, activities that prevent and predispose to relapse. Session 6: work, guilt, recovery motivation. The seventh session: truthfulness, complete purity. Session 8: Addictive sexual relationships, behaviors and thoughts related to relapse and its prediction.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Drug relapse prevention score in Wright questionnaire. Timepoint: Before the therapeutic interventions of Act and Matrix and after the completion of the interventions. Method of measurement: Wright addiction relapse prediction questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-12-05</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Marvdasht branch</contact_name>
        <contact_address>Islamic Azad University of Marvdasht ,Killometer three of Takht Jamshid Blvd , Marvdasht Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
